Bullish indicating open at $55-$60, IPO prices at $37
Brown & Brown Inc. stock reached a 52-week low, closing at $90.53. This milestone reflects a significant downturn for the insurance brokerage company over the past year. The stock’s value has decreased by 8.11% over the last 12 months, marking a challenging period for the firm amidst broader market volatility. With analyst price targets ranging from $87 to $130, and the RSI indicating oversold conditions, investors and analysts will be closely monitoring the company’s performance. For deeper insights, InvestingPro offers 12 additional key insights about Brown & Brown’s current position and future prospects.
In other recent news, Brown & Brown reported better-than-expected earnings for the second quarter of 2025, with earnings per share reaching $1.03, surpassing the forecasted $0.99. The company’s revenue also exceeded expectations, coming in at $1.29 billion. Despite these positive results, analysts have adjusted their outlooks for the company. Keefe, Bruyette & Woods lowered its price target to $87, citing slower organic growth and higher expenses. Truist Securities also reduced its target to $120, highlighting exposure to the Florida property market downturn but maintained a Buy rating, suggesting potential improvement ahead. BMO Capital decreased its target to $106, although it described the recent stock price drop as "overdone." In contrast, BofA Securities upgraded Brown & Brown to a Buy rating, raising its price target to $130, noting the stock’s significant underperformance relative to the S&P 500. These developments reflect a mix of cautious optimism and concern among analysts regarding the company’s future prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.